Douglas – Cohort studies
Douglas is part of a clinical trial about cholesterol. His participation usually involves having his blood taken. He does not mind this as long as the medical professional is skilled as he has had some bruising in the past.
Douglas has taken part in two medical studies. The first was about migraines and lasted about three months. In the migraine study, the research team gave Douglas some medication which he believes were placebos. He also had an ECG and had to fill in a diary. After his final appointment in the migraine study, the doctor told Douglas to come back into the surgery under the pretence that they needed to repeat a test for the study. At this appointment, Douglas was told that he had experienced a heart attack. At a later date, he was invited to a study looking at cholesterol levels which he has been enrolled in for two years.
The cholesterol study is a clinical trial run by a pharmaceutical company. Being in the study involves Douglas taking medicine and attending appointments where he has blood taken and information recorded, such as his height and weight. He does not mind having blood taken if the health professional is skilled; he has had some experiences where he has been bruised by less experienced people. One of the blood test results in the study came back as having low platelet levels. This led Douglas to be referred to a hospital where he was prescribed medication.
However, Douglas became concerned about the amount of tablets he was taking. When he spoke to the research nurse in the cholesterol study about possibly leaving the research, he was told, “well we wouldn’t actually like you to do that.” Douglas says that the research team were keen to keep him enrolled in the study and it was agreed that he could stop taking the study medication. He didn’t mind that they were insistent about his participation because he wanted to help society and medical knowledge. Douglas continues to take part in the study as he would not have found out about his heart attack or low platelet levels otherwise.
Douglas is motivated to turn up to his study appointments because the tests are very thorough. He feels that “for that alone it’s worth” attending the study appointments every few months. Most of the researchers he has seen have been very good, although he could recall two who were “not as strict and accurate as they could be.” Douglas is disappointed that he does not receive detailed information about his cholesterol levels, and he was once told by a researcher that the information could not be disclosed because it was part of the study data. Regardless, Douglas is happy that he receives information about his general health and he thinks it is worthwhile to take part in medical studies. His message to others who are invited to take part in medical research is to “give it a go.”
Interview conducted in 2019.